Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A
I Clinica Medica, University of Pisa, Italy.
Circulation. 1998 Jun 9;97(22):2222-9. doi: 10.1161/01.cir.97.22.2222.
Essential hypertension is associated with impaired endothelium-dependent vasodilation. Inactivation of endothelium-derived nitric oxide by oxygen free radicals participates in endothelial dysfunction in experimental hypertension. To test this hypothesis in humans, we evaluated the effect of antioxidant vitamin C on endothelium-dependent responses in essential hypertensive patients.
In 14 healthy subjects (47.1+/-4.8 years; blood pressure, 120.6+/-4.5/80.9+/-3.5 mm Hg) and 14 essential hypertensive patients (47.3+/-5.1 years; blood pressure, 153.9+/-7.1/102.3+/-4.1 mm Hg), we studied forearm blood flow (strain-gauge plethysmography) modifications induced by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 microg x 100 mL(-1) x min(-1)) or sodium nitroprusside (1, 2, and 4 microg/100 mL forearm tissue per minute), an endothelium-dependent and -independent vasodilator, respectively, in basal conditions and during infusion of intrabrachial vitamin C (2.4 mg/100 mL forearm tissue per minute). In hypertensive patients but not in control subjects, vitamin C increased (P<0.01) the impaired vasodilation to acetylcholine, whereas the response to sodium nitroprusside was unaffected. Moreover, in another 14 hypertensive patients (47.1+/-5.2 years; blood pressure, 155.2+/-6.9/103.7+/-4.5 mm Hg), the facilitating effect of vitamin C on vasodilation to acetylcholine was reversed by N(G)-monomethyl-L-arginine (100 microg/100 mL forearm tissue per minute), a nitric oxide synthase inhibitor, suggesting that in essential hypertension superoxide anions impair endothelium-dependent vasodilation by nitric oxide breakdown. Finally, because in adjunctive 7 hypertensive patients (47.8+/-6.1 years; blood pressure, 155.3+/-6.8/103.5+/-4.3 mm Hg), indomethacin (50 microg/100 mL forearm tissue per minute), a cyclooxygenase inhibitor, prevented the potentiating effect of vitamin C on vasodilation to acetylcholine, it is possible that in essential hypertension a main source of superoxide anions could be the cyclooxygenase pathway.
In essential hypertensive patients, impaired endothelial vasodilation can be improved by the antioxidant vitamin C, an effect that can be reversed by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. These findings support the hypothesis that nitric oxide inactivation by oxygen free radicals contributes to endothelial dysfunction in essential hypertension.
原发性高血压与内皮依赖性血管舒张功能受损有关。氧自由基使内皮源性一氧化氮失活参与了实验性高血压中的内皮功能障碍。为了在人体中验证这一假说,我们评估了抗氧化剂维生素C对原发性高血压患者内皮依赖性反应的影响。
在14名健康受试者(47.1±4.8岁;血压,120.6±4.5/80.9±3.5 mmHg)和14名原发性高血压患者(47.3±5.1岁;血压,153.9±7.1/102.3±4.1 mmHg)中,我们研究了在基础状态下以及臂内输注维生素C(2.4 mg/100 mL前臂组织每分钟)期间,臂内注射乙酰胆碱(0.15、0.45、1.5、4.5和15 μg×100 mL⁻¹×min⁻¹)或硝普钠(1、2和4 μg/100 mL前臂组织每分钟)分别引起的前臂血流(应变片体积描记法)变化,乙酰胆碱是内皮依赖性血管舒张剂,硝普钠是内皮非依赖性血管舒张剂。在高血压患者而非对照受试者中,维生素C增加了(P<0.01)对乙酰胆碱受损的血管舒张反应,而对硝普钠的反应未受影响。此外,在另外14名高血压患者(47.1±5.2岁;血压,155.2±6.9/103.7±4.5 mmHg)中,一氧化氮合酶抑制剂N(G)-单甲基-L-精氨酸(100 μg/100 mL前臂组织每分钟)逆转了维生素C对乙酰胆碱血管舒张的促进作用,提示在原发性高血压中,超氧阴离子通过一氧化氮分解损害内皮依赖性血管舒张。最后,因为在另外7名高血压患者(47.8±6.1岁;血压,155.3±6.8/103.5±4.3 mmHg)中,环氧化酶抑制剂吲哚美辛(50 μg/100 mL前臂组织每分钟)阻止了维生素C对乙酰胆碱血管舒张的增强作用,所以在原发性高血压中,超氧阴离子的一个主要来源可能是环氧化酶途径。
在原发性高血压患者中,抗氧化剂维生素C可改善受损的内皮血管舒张功能,一氧化氮合酶抑制剂N(G)-单甲基-L-精氨酸可逆转这一作用。这些发现支持了氧自由基使一氧化氮失活导致原发性高血压内皮功能障碍的假说。